Erratum: Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)

A. Von Drygalski; A. Giermasz; G. Castaman

doi:10.1182/bloodadvances.2020002987

Erratum: Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)

A. Von Drygalski, A. Giermasz, G. Castaman

Hematology and Oncology

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

A copy of the article's visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.

Original language	English (US)
Pages (from-to)	3668
Number of pages	1
Journal	Blood Advances
Volume	4
Issue number	15
DOIs	https://doi.org/10.1182/bloodadvances.2020002987
State	Published - Aug 11 2020

ASJC Scopus subject areas

Hematology

Access to Document

10.1182/bloodadvances.2020002987

Cite this

Erratum : Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811). / Von Drygalski, A.; Giermasz, A.; Castaman, G.

In: Blood Advances, Vol. 4, No. 15, 11.08.2020, p. 3668.

Research output: Contribution to journal › Comment/debate › peer-review

@article{4c6fa67a86774c51b6264ae5a6674a0f,

title = "Erratum: Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)",

abstract = "A copy of the article's visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.",

author = "{Von Drygalski}, A. and A. Giermasz and G. Castaman",

year = "2020",

month = aug,

day = "11",

doi = "10.1182/bloodadvances.2020002987",

language = "English (US)",

volume = "4",

pages = "3668",

journal = "Blood advances",

issn = "2473-9529",

publisher = "American Society of Hematology",

number = "15",

}

TY - JOUR

T1 - Erratum

T2 - Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)

AU - Von Drygalski, A.

AU - Giermasz, A.

AU - Castaman, G.

PY - 2020/8/11

Y1 - 2020/8/11

N2 - A copy of the article's visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.

AB - A copy of the article's visual abstract was erroneously published as the supplemental data file. It has been replaced by the correct supplemental data file.

UR - http://www.scopus.com/inward/record.url?scp=85095813451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85095813451&partnerID=8YFLogxK

U2 - 10.1182/bloodadvances.2020002987

DO - 10.1182/bloodadvances.2020002987

M3 - Comment/debate

C2 - 32777062

AN - SCOPUS:85095813451

VL - 4

SP - 3668

JO - Blood advances

JF - Blood advances

SN - 2473-9529

IS - 15

ER -

Erratum: Etranacogene dezaparvovec (AMT-061 phase 2b): Normal/near normal FIX activity and bleed cessation in hemophilia B (Blood Advances (2019) 3:21 (3241-3247) DOI: 10.1182/bloodadvances.2019000811)

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this